Zuvog Trio 1mg/500mg/0.2mg Tablet SR
Marketer
Zuventus Healthcare Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Zuvog Trio 1mg/500mg/0.2mg Tablet SR
Tri-Zyme 1mg/500mg/0.2mg extended-release tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer Tri-Zyme with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a readily available glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment; pregnancy and breastfeeding necessitate physician consultation. Regular blood glucose monitoring, along with blood cell and liver function tests as your doctor advises, are essential.
Primary Ingredients of Zuvog Trio 1mg/500mg/0.2mg Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Zuvog Trio 1mg/500mg/0.2mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Zuvog Trio 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zuvog Trio 1mg/500mg/0.2mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
Common Side effects of Zuvog Trio 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Zuvog Trio 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zuvog Trio 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Zuvog Trio 1mg/500mg/0.2mg Tablet SR works:
Each Zuvog Trio sustained-release tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zuvog Trio 1mg/500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Zuvog Trio 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Zuvog Trio 1mg/500mg/0.2mg tablet is likely not suitable for use while breastfeeding. Available human data indicate potential transfer to breast milk with possible infant risk.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Zuvog Trio 1mg/500mg/0.2mg SR tablets carries a high risk for individuals with kidney impairment and should be forgone. A physician's consultation is advised. Furthermore, its use is contraindicated in patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should use Zuvog Trio 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, treatment typically begins with a reduced Zuvog Trio 1mg/500mg/0.2mg SR tablet dosage; however, its use is contraindicated in patients exhibiting severe liver disease.
What if you forget to take Zuvog Trio 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Zuvog Trio 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zuvog Trio 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently